Wait — it's the day I take the loan from the 'family friend' investor.

The storm cleared from Chicago by Friday morning, leaving the city washed in a brilliant, razor-sharp light that made the glass towers of the Loop glitter like diamonds against the freezing blue sky.

I stood on the observation catwalk of the Vance Bio-Dynamic research facility in the Illinois Medical District, looking down into the main cleanroom through the three-inch reinforced glass partition.

The laboratory was a cathedral of human ingenuity.

Thirty-six researchers in white cleanroom suits, nitrile gloves, and HEPA respirators were moving with synchronized, focused precision between the four massive stainless-steel bioreactors humming on the lower deck. The automated digital status boards along the north wall were glowing entirely in steady, reassuring emerald green:

BIOREACTOR CLUSTER ALPHA: 37.0°C [STABLE].

CELLULAR HARVEST YIELD: 94.2% [OPTIMAL].

TREASURY RESERVE RUNWAY: 24 MONTHS [UNRESTRICTED].

The heavy airlock door behind me hissed open with a pneumatic sigh.

My lead research director, Dr. Maya Lin—the brilliant cellular geneticist who in my previous life had wept in my arms as we turned off the bioreactors forever—stepped onto the catwalk holding an iPad and two steaming paper cups of coffee.

She wasn't wearing a respirator; she wore her white lab coat over a simple black turtleneck, her dark hair pulled back into an efficient ponytail, her face glowing with an exhaustion that was entirely born of joy.

"Morning, Boss," Maya smiled, handing me a cup of black coffee and leaning her elbows against the brushed-steel railing beside me.

"Morning, Maya," I replied, taking a sip of the hot, bitter brew. It tasted of roasted chicory, fresh water, and absolute victory. "How are the second-passage neuronal assays looking?"

"Take a look yourself," she said, tapping her tablet and spinning the screen toward me.

The screen displayed a high-resolution confocal microscopic feed of human motor neuron cultures. The damaged axonal pathways—the exact biological signature of degenerative ataxia that had killed my sister twenty years ago—were visibly regenerating, extending new synaptic branches across the collagen scaffold in real time.

"The cellular integration rate is eighty-nine percent," Maya whispered, her voice trembling with an emotion that went far beyond professional pride. "The FDA reviewed the preliminary telemetry thirty minutes ago. Dr. Reyes signed off on the Phase II expedited clinical protocol. We’re dosing our first twelve human trial subjects at Northwestern Memorial on December first."

I closed my eyes for three seconds, letting the words settle into my marrow.

Twelve human beings. Twelve families who would not have to watch their children wither in wheelchairs while corrupt billionaires argued over liquidation preferences in Gold Coast conservatories.

"Did the employee equity distributions clear the bank, Maya?" I asked, looking out over the busy floor.

"Every single technician, researcher, and maintenance specialist received their vesting certificates at nine o'clock," Maya confirmed, her eyes shining behind her glasses. "Twenty percent of the company’s common stock, held in an irrevocable employee trust. Arthur Sterling couldn't dilute this team now if he had an army of a thousand lawyers."

A soft, sharp chime sounded from the master terminal on the observation desk.

The morning news feed on the wall monitor updated with a special breaking report from Bloomberg Television:

“STERLING STRATEGIC HOLDINGS COLLAPSES INTO RECEIVERSHIP; SEC FREEZES $1.2B IN ASSETS AS PATRIARCH ARRAIGNED ON FEDERAL FRAUD CHARGES.”

Below the headline was a photograph of Arthur Sterling being led down the granite steps of the Dirksen Federal Building, his face shielded by a rumpled wool coat, his hands locked in federal steel irons.

Maya looked at the screen, then turned to look at me, her brow furrowing with quiet, unhurried wonder.

"Leo," she asked softly, "when you walked out of that laboratory on Wednesday morning... you looked like a man heading to his own funeral. You looked like you were carrying a mountain on your back."

She stepped closer, resting her hand gently on my forearm.

"What changed between Wednesday night and Thursday morning? What made you stop? What made you read every single clause of that contract?"

I looked down at my left wrist, where my grandfather’s vintage gold Omega was ticking with steady, unbroken rhythm.

"A wise man once told me, Maya," I replied, looking down into the cleanroom where life was multiplying by the billions in the light, "that a predator always hides his sharpest teeth behind the word family. And if you don't take the time to read the ink... you let them eat your future for breakfast."

Maya smiled, raising her paper cup in a gentle toast.